Abstract
Seborrhoeic dermatitis is a common chronic inflammatory disorder of the skin, characterized by scaly, erythematous patches mainly involving the sebum-rich areas like the scalp, face back and upper chest. The pathogenesis of seborrheic dermatitis is not fully understood, but the colonization of skin with lipophilic yeasts Malassezia, along with genetic, environmental and overall health factors, contribute to its pathogenesis. A large number of treatment modalities are used, which include the clearance of fungus by the application of antifungals like pyrithione zinc or ketoconazole-containing shampoos, keratolytics like selenium sulphide, reducing the inflammation by topical corticosteroids and reducing sebum production by oral retinoids.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brenner S, Horwitz C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators: essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C selenium; zinc; iron. World Rev Nutr Diet. 1988;55:165–82.
Caputo R, Barbareschi M, Gorani A, Veraldi S. Itraconazole: new horizons. In: Congress of the European academy of dermatology & venereology. 2002. 16(suppl 1), pp. 254–254.
Cook BA, Warshaw EM. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. Am J Clin Dermatol. 2009;10:105–16.
Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double blind, placebo controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29:1008–12.
Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011;4:32–8.
Dreno B, Moyse D. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double blind study versus placebo. Eur J Dermatol. 2002;12:549–52.
Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrheic dermatitis to ketoconazole. Br J Dermatol. 1984;111:603–7.
Fredriksson T. Controlled comparison of clinitar shampoo and Selsun shampoo in the treatment of seborrheic dermatitis. Br J Clin Pract. 1985;39:25–8.
Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13–26; quiz, 19–20.
Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208(2):89–93.
Mahe A, Simon F, Coulibaly S, Tounkara A, Bobin P. Predictive value of seborrheic dermatitis and other common dermatoses for HIV infection in Bamako, Mali. J Am Acad Dermatol. 1996;34(6):1084–6.
Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased sebum excretion, and Parkinson’s disease: a survey of (im)possible links. Med Hypotheses. 2003;60:907–11.
Mokos ZB, Kralj M, Basta-Juzbasic A, Jukic IL. Seborrheic dermatitis: an update. Acta Dermatovenerol Croat. 2012;20(2):98–104.
Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998;196:140–7.
Ortonne JP, Lacour JP, Vitetta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrheic dermatitis in adults. Dermatology. 1992;184:275–80.
Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 1995;132:441–5.
Piérard GE. Seborrheic dermatitis today, gone tomorrow? The link between the biocene and treatment. Dermatology. 2003;206:187–8.
Pierard-Franchimont C, Goffin V, Decroix J, Pierard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002;15:434–41.
Pirkhammer D, Seeber A, Hönigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol. 2000;143:964–8.
Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopiroxolamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatol Treat. 2007;18:88–96.
Scaparro E, Quadri G, Virno G, Orifici C, Milani M. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil®) in patients with seborrheic dermatitis. A multicentre, randomized, investigator blinded, placebo-controlled trial. Br J Dermatol. 2001;144:854–7.
Stratigos JD, Antoniou C, Katsambas A, Böhler K, Fritsch P, Schmöl A, et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis: a double-blind comparative study. J Am Acad Dermatol. 1988;19:850–3.
Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol. 2007;57:257–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goldust, M., Gupta, M. (2023). Seborrhoeic Dermatitis. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_86
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_86
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)